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multiple interactions on a single invoice. [14] Within the practitioner bills, individual procedures are linked to diagnosis codes, procedure modifiers, and costs. Consequently, a visit should link both the facility and the practitioner information without changing the existing practitionerspecified relationships between procedures, modifiers, diagnoses, and costs. Even electronic medical records can be challenging when each interaction with a different provider (e.g., nurse, physician, pharmacist, etc.) is recorded separately, requiring decisions to be made about defining a visit.
To minimize the need to encode specific relationships that may not exist in the source data, we created a data model with a hierarchical structure that minimizes changes to the meaning of the original data. This data model can serve both as a stand-alone data model for clinical researchers using observational data, as well as a storage model for later conversion into other data models. 
Generalized Data Model

Methods
In designing the Generalized Data Model (GDM) the primary use case was to allow clinical researchers using commonly available observational datasets to conduct research efficiently using a common framework. In particular, the GDM was designed to allow researchers to reuse an extensive, published body of existing algorithms for identifying clinical research constructs, including visits, that are expressed in the native vocabularies of the raw data. These algorithms require code sets, and may also require temporal logic (e.g., before, after, during, etc.), sequencing information (e.g., first, last, etc.), and provenance information (e.g., inpatient, outpatient, etc.). The GDM specifically considered both oncology research, which has its own specific vocabularies, and health services research. However, the model was designed so that these specific focus areas would not limit the design or use of the model.
Design goals
We initiated development of the GDM to make ETL specification and implementation easier for users who work with data models. There were two primary goals in defining the standard tables and table relationships for the GDM, described below.
Focus on clinical codes in their original vocabularies
For clinical research, transparency and reproducibility are critically important. Therefore, the model is focused on the original (source) vocabularies to prevent the loss of the original semantic expression of the underlying clinical information. We also wanted all clinical codes (e.g., International Classification of Diseases [ICD], Current Procedural Terminology, National Drug Codes, etc.) to be easy to load into the data model and easy to query, because they represent the majority of electronic clinical information. Hence, the key organizing structure of the GDM is the placement of all clinical codes in a central "fact" table. This is not unlike the i2b2 data model that uses a fact table to store all "observations" from a source data set; however, the GDM was not designed as a star schema despite the similar idea of locating the most important data at the center of the data model.
We also considered interoperability as part of the design, but it was of secondary importance.
Interoperability, like the construction of visits, requires establishing new connections ("mappings") between the source vocabularies and a standard vocabulary such that a single query can operate across all data sources regardless of the source vocabulary. For international studies using different vocabularies, this might be a useful tool. However, given that every code isn't yet mapped to a standard (e.g., OMOP has little in the way of procedure code mappings), and the maintenance required to support and update mappings, we designed the GDM to incorporate reliable cross-vocabulary mappings where they exist.
Retain hierarchical information with provenance
The second goal was to capture important hierarchical relationships among data elements Our review of data sources suggested that the data model needed to support relatively few relationship types. The primary relationship represents data that is reported together or collected at the same time. One example of this includes a "line", which occurs in claims data when one or more diagnosis codes, a procedure code, and a cost are all reported together. Another example includes laboratory values assessed at the same time (e.g., systolic and diastolic blood pressure) which could be considered to be co-reported. Also, a set of prescription refills could represent a linked set of records. Even records that contain precoordinated expressions (i.e., a linked set of codes used to provide clinical information akin to an English sentence) could also be stored in order by associating the codes with a single
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Context record.
We also included the provenance for each clinical code as part of Contexts, recording not only the type of relationship among elements within a Context as discussed above, but also the source file from which the data was abstracted. To minimize the loss of information when converting from the GDM to a data model that uses visits for organizing and consolidating most data relationships, the GDM does not require explicit visits (see Results). This is important because visits are not consistently defined among other data models, particularly for administrative claims data (see Discussion).
Other Considerations
There are several other considerations made in building this data model, some of which were borrowed or adapted from other data models. For example, in addition to the cost table, we borrowed the OMOP idea to store all codes as "concept ids" (unique numeric identifiers for each code in each vocabulary to avoid conflicts between different vocabularies that use the same code). We also expanded upon the idea of OMOP "type_concept_ids" to track provenance within our data model. Finally, we allow flexibility in storing enrollment information in the Information Periods table using a "type_concept_id" so that the data can be used for different purposes (e.g., if a protocol does not require drug data, then enrollment in a drug plan should not be required). We also wanted to facilitate a straightforward, subsequent ETL process to other data models, including OMOP, Sentinel, and PCORnet. 
Test Data
We tested the data model on three very different types of commonly available data used by Medicare beneficiaries from 2008 who were followed for three years, created to facilitate software development using Medicare data. [18, 19] We also implemented an ETL for SEER data linked to Medicare claims data [20] for 20,000 patients with small cell lung cancer, as part of an ongoing research project to describe patterns of care in that population. Finally, we developed a complete ETL for 140,000 CPRD patients for an ongoing research project evaluating outcomes associated with adherence to lipid-lowering medications. We also tested the feasibility of an ETL process to move SynPUF data from the GDM to the Sentinel data model (version 6.0) to ensure that the model did not contain any structural irregularities that would make it difficult to move data into other data model structures.
Finally, we conducted a test of information loss in the context of applying quality control to a study of mesothelioma patients. We conducted two analyses by separate people based on a written specification document using SEER Medicare data. The first was conducted using the source data and a combination of SAS and R code, and the second was conducted using the GDM version of the data and proprietary software. The analysis required the use of several SEER-specific fields, including the tumor sequence (first primary), histology, reporting type (microscopic confirmation), reporting source (not at death or autopsy), and tumor location data.
ETL Software
Our ETL process focused on the extraction of the source data and the transformation to the GDM data model, and saved tables as .csv files (i.e., it focused primarily on the E and T parts of the ETL). The ETL processes were built using R (version 3.4.4) and the data. 
Results
The resulting data model contains 19 tables (see hierarchical view in Figure 2 ). Details of the tables are provided in Supplementary Materials, and the most up-to-date version is available on a GitHub repository. [23] This repository will also contain links to any publicly available ETL specifications that we develop.
Tables
Clinical Data
The Clinical Codes, Contexts, and Collections tables make up the core of the GDM (as shown in This kind of grouping occurs when multiple billable units ("lines" or "details") are combined into invoices ("claims"). It also occurs when prescriptions, laboratory measures, diagnoses and/or procedures are all recorded at a single office visit. In short, a Collection is typically a "claim" or a "visit" depending on whether the source data is administrative billing or electronic health record data. By using a hierarchical structure, the model avoids the requirement to construct "visits" from claims data which often leads to inaccuracy, loss of information, and complicated ETL processing. In the simplest possible case, it is possible to have a single record in the Clinical Codes table which is associated with a single Context record, which is associated with a single Collection record, as shown in Figure 1 for a drug record. The critical part of the ETL process, moving data into the Clinical Codes, Contexts, and Collections tables, is described in Figure 3 for the SynPUF data. 
Facility and Practitioner Data
The Facilities 
Vocabulary Data
The Concepts table provides a unique numeric identifier ("concept_id") for each source code in each vocabulary used in the data (see Table 1 ). Since queries against the GDM are intended to use the source codes, the Vocabulary The Mappings table is designed to express relationships among data elements. It can also be used to facilitate translation into other data models (see Table 2 ). In a few very simple cases like sex and race/ethnicity, we recommend concept mappings to a core set of values to make it easier for users of a protocol implementation software to filter patients by age, gender, and race/ethnicity using a simpler representation of the underlying information. The Mappings table also permits an arbitrarily complex set of relationships, along the lines of the approach taken with the OMOP model and the use of standard concepts for all data elements. By using a Mappings 
ETL Results
We loaded SynPUF data and SEER Medicare data into the GDM. After downloading the data to a local server, the process of migrating the SynPUF data with 2. (see Table 1 ). 
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Information Loss
After reconciling differences in interpretation and resolving coding errors, we identified the identical cohort of patients when using the source data compared to using the same data in the GDM.
ETL from the GDM to Sentinel
We conducted an exploratory transformation from the GDM to Sentinel to ensure that it was feasible. The process of moving the data was conducted as follows. 
Discussion
The GDM is designed to allow clinical researchers to identify the clinical, resource utilization, and cost constructs needed for a wide range of epidemiological and health services research areas without altering the data's original semantics by creating visits or domains, or performing substantial vocabulary mapping. This provides flexibility for researchers to study not only clinical encounters like outpatient visits, hospitalizations, emergency room visits, and episodes of care, but also more basic constructs like conditions or medication use. Its main goal is to simplify the location of the most important information for creating analysis data sets, which has the benefit of making ETL easier. It does this by using a hierarchical structure instead of visits.
It tracks the provenance of the original data elements to enhance the reproducibility of studies.
It includes a table to store relationships among data elements for standardized analyses. And it allows for a subsequent ETL process to other data models to provide researchers access to the analytical tools and frameworks associated with those models.
Because other data models (e.g., OMOP, Sentinel, PCORnet, and i2b2) use visits to connect patient-related information within the data model, our emphasis on avoiding visits deserves comment. Visits are seldom required for clinical research, unless the enumeration of explicit visits is the research topic itself. However, for most research projects, protocols require retrieval of the dates of specific, clinically relevant codes, perhaps with provenance or temporal constraints. Satisfying these criteria does not require knowledge of a visit, per se. It is a research project in and of itself to define visits, and their definitions are specific to the health services research question being investigated. [14] For example, a study of "emergency department" visits would need to consider at least four options to define a visit. [24] Data models that pre-define visits do not allow such flexibility.
The challenges with visits can best be seen by inspecting the guidelines for creating visits from each data model. In the Sentinel version 6 data model [10] , a visit is defined as a unique In the OMOP version 5.31 data model, a visit is defined for each "visit to a healthcare facility."
According to the specifications [6] , in any single day, there can be more than one visit. One visit may involve multiple providers, in which case the ETL must either specify how a single provider is selected or leave it null. One visit may involve multiple care sites, in which case the ETL must either specify how a single site is selected or leave it null. Visits must be given one of the following visit types: Inpatient Visit, Outpatient Visit, Emergency Room Visit, Long Term Care Visit and Combined ER and Inpatient Visit. OMOP added an optional Visit Detail table in version 5.3, recognizing the two-level hierarchy common in US claims data. [6] For i2b2, the specifications state a visit ". . . can involve a patient directly, such as a visit to a doctor's office, or it can involve the patient indirectly, as in when several tests are run on a tube of the patient's blood. More than one observation can be made during a visit. All visits must have a start date / time associated with them, but they may or may not have an end date. The visit record also contains specifics about the location of the session, such as the hospital or clinic the session occurred and whether the patient was an inpatient or an outpatient at the time of the visit." There are no specified visit types, and the data model allows for an "unlimited Clearly, each data model has different perspectives on the definition of a visit. Such ambiguity can lead to differences in how tables are created in the ETL process. As a result, inconsistencies within or across data models can lead to differences in results, as has already been demonstrated. [25, 26] Laboratory records could be visits as with i2b2, or could be associated with visits as with other data models. Similarly, prescription, refill, and pharmacy dispensing records could be considered visits, or associated with visits. And other information, like family history, might not require a visit at all. In short, the most important structural component of other data models cannot be accurately and consistently defined, which affects the consistency of analyses across the data models, and makes translation among data models problematic. This also undermines provenance since each data model might answer the question of "where did this record come from" using different visit types. However, we note that these are semantic considerations and not technical limitations for record retrieval. For example, the i2b2 query platform recently has been extended to permit querying of OMOP and PCORnet data. [28] One important consideration in using data models is their stability. It can be labor-intensive to keep data updated, and if both the data and the data model are changing, maintenance may be prohibitively time-consuming. [13] One of our intentions is that the GDM should remain stable over time; therefore, we incorporated separate Vocabulary and the Mappings tables which can be updated without running the ETL from the beginning. Hence, the GDM may be a useful, harmonized approach for data providers, compared to their various proprietary solutions. This contrasts with the OMOP data model which requires re-running the ETL when the vocabulary and domain mappings are updated.
The value of domains is that they allow data users to identify the necessary clinical information to extract for analysis and they facilitate interoperability. However, moving raw healthcare data into domains requires either mapping the entire vocabulary into a single domain, or mapping each individual code into a single domain. Placing codes in domain-specific tables can be particularly challenging when vocabularies cross domains (e.g., Read) or when individual codes are ambiguous (e.g., family history information). The GDM does not require domains or vocabulary mappings to be fully functional. The GDM only requires that users assign a unique number (concept id) to all unique source codes in a given dataset to ensure consistency in the data type for the codes. The vocabulary table is simply a look-up table for the codes and concept ids. Because of this, all codes in all vocabularies (e.g., ICD-9, HCPCS, etc.) in the source data will be retained unless there is an explicit decision to exclude a code. However, if needed, the GDM could support domains as an additional field in the Vocabulary table.
It is important to clarify the role of analyses in the ecosystem of data models. Neither the GDM nor any other data model is designed to support direct analyses of any sophistication on the entire database (excluding summary analyses to characterize the entire dataset). The role of the data model is to ease the extraction and organization of analysis data sets to address specific clinical research questions. The required analysis dataset structure depends on the specific analyses (e.g., prevalence, incidence, time to event, repeated measures, etc.) and is typically performed using R (OHDSI) or SAS (Sentinel). By starting with the GDM, researchers can develop tools to extract data directly, or implement the necessary transformations to migrate their data to other data models and make use of the tools for extraction and analysis offered by those models. While this requires another ETL process, or a database view to be created on the GDM, it facilitates access to existing analytical tools. Hence, the GDM can be used as a standardized waypoint in a data pipeline because the necessary information for other We should also note that our approach to incorporating relationships into the data (i.e., our Mappings table) is not unique. Others have designed approaches that rely on semantic mappings to organize and extract data. [30] There are even methods to eliminate the need for both database reorganization and semantic mapping. [31] While these approaches may be more flexible and avoid cumbersome ETL and/or mapping processes, it is unclear how they fare with respect to the sensitivity and specificity of their exposure and outcome definitions making it challenging to understand or assess bias in their results. [32, 33] Information loss and data quality assessment are challenging subjects. We designed the GDM to minimize information loss in the sense that any codes in the source data can be incorporated by creating entries in the Concepts, Vocabularies, and Clinical Codes tables. We also retained database specific provenance information by indicating the source file from which each data element is derived as well as the type of information that was derived. While we tested information loss in the context of a cohort study and found no problems, this is not a guarantee that all necessary information is, or can be, retained. A more robust assessment of data quality will be the subject of future research. However, our use of the SEER data is illustrative because detailed oncology data does not fit naturally into any of the other data models mentioned. 
Conclusion
The GDM is designed to retain the relationships among data elements to the extent possible, facilitating ETL and protocol implementation as part of a complete data pipeline for clinical researchers using commonly available observational data. Furthermore, by avoiding the requirements to create visits and to use domains, it offers researchers a simpler process of standardizing the location of data in a defined structure and may make it easier for users to transform their data into other data models.
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